PKI-179

PKI-179 is a second-generation ATP small molecule mimetic targeting the mammalian target of rapamycin (mTOR) with potential anti-tumor activity. PKI-179 selectively inhibits mTOR and phosphoinositide 3-kinase (PI3K) α, and by inhibiting the PI3K/mTOR signaling pathway, the drug can inhibit tumor cell proliferation and survival.

• Supplier: Alfa Cytology
• Product #: BC0188